-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2004 - .**
4490: POISON&TOXIC EFFECTS DRUGS AGE>17 W/O CC 1594 0.20
4491: POISON&TOXIC EFFECTS DRUGS AGE>17 … W CC 2134 0.27
4492: POISON&TOXIC EFFECTS DRUGS AGE>17 W MCC 818 0.10
4510: POISON&TOXIC EFFECTS DRUGS … 0-17 W/O CC 431 0.05
4511: POISON&TOXIC EFFECTS DRUGS 0-17 W CC 127 0.02
4512: POISON&TOXIC EFFECTS … DRUGS 0-17 W MCC 38 0.00
4520: COMPLICATIONS OF TREATMENT W/O CC 595 0.07
4521: COMPLICATIONS OF TREATMENT … of Environment and Other External Causes 298 0.04
TRA81: Injury: Other 1067 0.13
TRA82: Poisoning: Drugs
-
psnet.ahrq.gov/node/49421/psn-pdf
October 01, 2003 - Urine a Tough Position
October 1, 2003
Gandhi TK. Urine a Tough Position. PSNet [internet]. 2003.
https://psnet.ahrq.gov/web-mm/urine-tough-position
The Case
A 22-year-old unmarried woman came to her doctor’s office worried that she might be pregnant. Although
she did not want to have a baby at that time, she sta…
-
digital.ahrq.gov/ahrq-funded-projects/machine-learning-validation-medication-regimen-complexity-critical-care
March 31, 2025 - Machine Learning Validation of Medication Regimen Complexity for Critical Care Pharmacist Resource Prediction
Project Description
Publications
Research Story
Creating a visualization tool that applies innovative machine learning prediction methods may improve health…
-
psnet.ahrq.gov/perspective/conversation-withdavid-c-classen-md-ms
May 01, 2012 - In Conversation With…David C. Classen, MD, MS
May 1, 2012
Also Read an Essay
Citation Text:
In Conversation With…David C. Classen, MD, MS. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 20…
-
psnet.ahrq.gov/web-mm/empiric-steroids-good-bad-and-ugly
June 01, 2015 - glucocorticoid-induced osteoporosis.( 4 ) Early intervention could include nonsteroidal antiinflammatory drugs … addition, his commentary does not include information regarding investigational or off-label use of pharmaceutical … products or medical devices.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
December 15, 2003 - Efficacy trials have also examined several drugs developed for non-weight-related purposes. … , 33 , 84-88 8 evaluated orlistat; 89-96 2 evaluated metformin; 81 , 97 and 1 evaluated multiple drugs … Weight maintenance trials suggest that prolonged therapy with these drugs confers some benefit, but that … Other drugs show inconsistent or short-term benefit. … 0.001
7.5%
Good
Lifestyle
-5.6 kg
-5.5 kg
Placebo
-0.1 kg
Multiple Drugs
-
digital.ahrq.gov/ahrq-funded-projects/impact-office-based-e-prescribing-prescribing-processes-and-outcomes/annual-summary/2011
January 01, 2011 - Impact of Office-Based E-Prescribing on Prescribing Processes and Outcomes - 2011
Project Name
Impact of Office-Based E-Prescribing on Prescribing Processes and Outcomes
Principal Investigator
Fischer, Michael
Organization
Brigham and Women's Hospital
Funding Mechanis…
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/comformat2006-011207.txt
December 12, 2006 - /******************************************************************/
/* Title: CREATION OF FORMAT LIBRARY FOR COMORBIDITY GROUPS */
/* COMORBIDITY SOFTWARE, VERSION 3.1 */
/* */
/* Description: …
-
psnet.ahrq.gov/web-mm/patient-safety-and-adherence-self-administered-medications
September 29, 2011 - The Commentary "Drugs don't work in people who don't take them." – C.
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/co-nm-specialinnovation.pdf
January 01, 2020 - awareness
campaign, and SBHC staff developed youth-friendly
resources regarding marijuana and other drugs
-
digital.ahrq.gov/sites/default/files/docs/page/Crandall.ppt
September 01, 2005 - Chain
OUR MEANS TO TRANSFORM HEALTH CARE FOR THE 21ST CENTURY
INCREASING DEMAND
DEMOGRAPHICS
DRUGS
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017837-feldman-final-report-2012.pdf
January 01, 2012 - The number of drugs and complexity of medication
regimens found among home health patients pose significant … However, the number of drugs and complexity of medication regimens
found among home health patients
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
November 28, 2012 - Chemoembolization
drugs and embolic
mixtures also changed a
great deal prior to 2000
and are now
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
September 24, 2024 - or
pharmacological treatment, including dietary
supplements and FDA-approved prescription or OTC
drugs … Prescriptions drugs
and OTC medications that are
not FDA-approved or available
in the United States
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
October 12, 2015 - including in vitro fertilization (IVF); 15 percent artificial insemination with fertility-
enhancing drugs … PCOS, use of ovulation-induction
agents including oral (clomiphene citrate or letrozole) and injected drugs … Use of fertility drugs and risk of ovarian
cancer: results from a U.S.-based case-control study. … Risk of ovarian cancer in women treated with ovarian
stimulating drugs for infertility. … Ovulation-inducing drugs and ovarian cancer risk:
results from an extended follow-up of a large United
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qpv8h6ZMbYLYzakVrNQoj2
October 11, 2022 - but 9
were conducted exclusively in adolescents
Pharmacotherapy studies were limited to
first-line drugs … but 5
were conducted exclusively in adolescents
Pharmacotherapy studies were limited to
first-line drugs … Fourth, the review was limited to
first-line drugs approved for pediatric use by the FDA. … Accessed February 15, 2021. https://www.fda.gov/
drugs/postmarket-drug-safety-information-
patients-and-providers … Suicidality in pediatric patients treated with
antidepressant drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - Pharmaceuticals (Basel). 2022 Jan
14;15(1):14. doi: 10.3390/ph15010100.
PMID: 35056154. … J
Psychoactive Drugs. 2021:1-10. doi:
10.1080/02791072.2020.1864069. PMID:
33393877. … Drugs.81(18):2103-16. PMID:
34800285. Exclusion reason: Ineligible
publication type
69. … Drugs.
2013 Oct;73(15):1711-22. doi:
10.1007/s40265-013-0125-0. PMID:
24085618. … CNS Drugs. 2021;21:21. PMID: 34802112.
Exclusion reason: Used as source
document
163.
-
psnet.ahrq.gov/perspective/conversation-georgia-galanou-luchen-pharm-d
October 24, 2021 - In Conversation With... Georgia Galanou Luchen, Pharm. D.
October 24, 2021
Also Read the Essay
Citation Text:
In Conversation With.. Georgia Galanou Luchen, Pharm. D. PSNet [internet]. 2021.In Conversation With... Georgia Galanou Luchen, Pharm. D.. PSNet [interne…
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017163-baker-final-report-2011.pdf
January 01, 2011 - 1
FINAL REPORT
Using Precision Performance Measurement to Conduct
Focused Quality Improvement
Principal Investigator: David W. Baker, MD, MPH
Team Members: Steven Persell, MD, MPH; Abel Kho, MD; Nancy Dolan, MD; Muriel Jean-
Jacques, MD
Organization: Northweste…
-
cds.ahrq.gov/cdsconnect/artifact/managing-chronic-pain-prescription-drug-monitoring-program-pdmp-medication
November 17, 2020 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates